Menu
Scroll to Top
Locations
San Francisco, CA, USA · Brisbane, CA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Other
founded in
2009
Delpor is a clinical-stage biopharmaceutical company that utilizes innovative technologies to develop once-yearly therapies for chronic diseases, focusing on CNS conditions such as schizophrenia and opioid use disorder. Their unique drug delivery system involves a small, non-mechanical subcutaneous implant that allows for sustained release of medications, improving patient adherence and treatment outcomes. Delpor is currently advancing several products through clinical trials, including DLP-114 for schizophrenia and a naltrexone implant for opioid addiction, positioning itself as a leader in long-acting therapies for chronic conditions.
Something looks off?